The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2019

Filed:

Aug. 03, 2016
Applicant:

Samumed, Llc, San Diego, CA (US);

Inventors:

Sunil Kumar KC, San Diego, CA (US);

David Mark Wallace, San Diego, CA (US);

Jianguo Cao, San Diego, CA (US);

Chandramouli Chiruta, San Diego, CA (US);

Joseph Timothy Marakovits, Encinitas, CA (US);

Venkataiah Bollu, San Diego, CA (US);

John Hood, San Diego, CA (US);

Assignee:

Samumed, LLC, San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 519/00 (2006.01); C07D 471/04 (2006.01); C07D 235/00 (2006.01); A61P 35/00 (2006.01); A61P 19/08 (2006.01); A61P 19/00 (2006.01);
U.S. Cl.
CPC ...
C07D 519/00 (2013.01); A61P 19/00 (2018.01); A61P 19/08 (2018.01); A61P 35/00 (2018.01); C07D 235/00 (2013.01); C07D 471/04 (2013.01);
Abstract

The present disclosure relates to 4-Azaindazole compounds having the following structure: or a pharmaceutically acceptable salt thereof, for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of a 4-azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.


Find Patent Forward Citations

Loading…